Researchers are excited about the medication , a groundbreaking dual treatment showing remarkable data in early trials for size reduction . It acts by targeting two pathways : GLP-1 and GIP, which , when https://hannaadiw358931.targetblogs.com/41087565/a-new-prospect-for-weight-management